Beta Bionics Inc (BBNX) Stock Price, Quote & News

Company Profile

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without t...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 427 7785

Website: www.betabionics.com

Address:

11 Hughes, Irvine, United States

jheerdink Aug. 8 at 8:57 PM

$MODD Here's another pic from Modular's Pivot tubeless patch pump booth today at ADCES $BBNX

1 · Reply

Disvan Aug. 7 at 4:07 PM

$BBNX under the radar w. only 178 watchers

0 · Reply

smartkarma Aug. 5 at 11:52 AM

$BBNX | Beta Bionic Inc (BBNX) Six Month Summary: From Breakout to Breakdown "Company prices upsized share offering above initial range, opens 29.4% higher. Stock broke below IPO price in March but recent quarterly may begin to give long term investors more confidence." - IPO Boutique (IPO Boutique) Read more: https://www.smartkarma.com/insights/beta-bionic-inc-bbnx-six-month-summary-from-breakout-to-breakdown

0 · Reply

lordbealish Jul. 31 at 1:00 PM

Under radar today $AMBQ $MAMK $BBNX

0 · Reply

JarvisFlow Jul. 30 at 3:42 PM

Truist Securities has updated their rating for Beta Bionics ( $BBNX ) to Buy with a price target of 21.

0 · Reply

JarvisFlow Jul. 30 at 2:21 PM

Baird has updated their rating for Beta Bionics ( $BBNX ) to Neutral with a price target of 17.

0 · Reply

Sam_Bass Jul. 30 at 2:08 PM

$BBNX super quarter and CEO is quite clear speaking about company’s revenue and growth visibility. Unique product pipeline too.

0 · Reply

d_risk Jul. 30 at 12:01 PM

$BBNX - Beta Bionics, Inc. - 10Q - Updated Risk Factors BBNX’s 2025 10-Q risk factors show refined financial and timing updates, removal of insulin device market acceptance risk, added cybersecurity, inventory forecasting, acquisition, and product liability risks, intensified competition and regulatory challenges, expanded clinical trial and supply chain risks, plus new stock volatility, insurance, and litigation exposures—all reflecting growth, innovation, and operational scaling complexities. #MedicalDevices #ClinicalTrials #SupplyChain #RegulatoryChallenges #Cybersecurity 🟢 Added 🟠 Removed https://d-risk.ai/BBNX/10-Q/2025-07-29

0 · Reply

d_risk Jul. 30 at 11:59 AM

0 · Reply

idan_vaknin Jul. 29 at 8:56 PM

$BBNX looks like a great company

0 · Reply

Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 4:02 PM EDT - 15 days ago

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

Jul 2, 2025, 7:30 AM EDT - 6 weeks ago

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025

Jun 19, 2025, 7:00 AM EDT - 2 months ago

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor

May 10, 2025, 10:05 AM EDT - 3 months ago

Beta Bionics, Inc. (BBNX) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:02 PM EDT - 3 months ago

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

May 1, 2025, 8:00 AM EDT - 3 months ago

Beta Bionics to Present at the Bank of America Securities Health Care Conference

Apr 24, 2025, 11:44 AM EDT - 4 months ago

Beta Bionics: Slowing Down Or Being Conservative?

Apr 9, 2025, 7:30 AM EDT - 4 months ago

Beta Bionics to Host Investor Event on June 22, 2025

Mar 27, 2025, 4:45 PM EDT - 4 months ago

Beta Bionics Announces Board Appointment of Gerard Michel

Mar 25, 2025, 4:02 PM EDT - 5 months ago

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

Feb 27, 2025, 7:00 AM EST - 6 months ago

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Feb 2, 2025, 9:43 AM EST - 6 months ago

Beta Bionics: A Sugar Rush For This IPO

Feb 1, 2025, 2:10 AM EST - 6 months ago

U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs

CSAI INR MAZE MTSR ODTX ODYS SAIL

Jan 31, 2025, 5:56 PM EST - 6 months ago

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jan 29, 2025, 10:34 PM EST - 7 months ago

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

Jan 11, 2025, 12:20 AM EST - 7 months ago

U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline

CEPO CRGT FLOC MIMI POAS SFD ZYBT

Jan 10, 2025, 11:36 AM EST - 7 months ago

Beta Bionics Aims For IPO To Cover Heavy Losses

Jan 6, 2025, 5:54 PM EST - 7 months ago

Insulin delivery device maker Beta Bionics files for a $100 million IPO

Jan 6, 2025, 5:14 PM EST - 7 months ago

Beta Bionics Files Registration Statement for Proposed Initial Public Offering

Jan 6, 2025, 4:25 PM EST - 7 months ago

Beta Bionics IPO Registration Document (S-1)

jheerdink Aug. 8 at 8:57 PM

$MODD Here's another pic from Modular's Pivot tubeless patch pump booth today at ADCES $BBNX

1 · Reply

Disvan Aug. 7 at 4:07 PM

$BBNX under the radar w. only 178 watchers

0 · Reply

smartkarma Aug. 5 at 11:52 AM

0 · Reply

lordbealish Jul. 31 at 1:00 PM

Under radar today $AMBQ $MAMK $BBNX

0 · Reply

JarvisFlow Jul. 30 at 3:42 PM

Truist Securities has updated their rating for Beta Bionics ( $BBNX ) to Buy with a price target of 21.

0 · Reply

JarvisFlow Jul. 30 at 2:21 PM

Baird has updated their rating for Beta Bionics ( $BBNX ) to Neutral with a price target of 17.

0 · Reply

Sam_Bass Jul. 30 at 2:08 PM

$BBNX super quarter and CEO is quite clear speaking about company’s revenue and growth visibility. Unique product pipeline too.

0 · Reply

d_risk Jul. 30 at 12:01 PM

0 · Reply

d_risk Jul. 30 at 11:59 AM

0 · Reply

idan_vaknin Jul. 29 at 8:56 PM

$BBNX looks like a great company

0 · Reply

BigSqueezeComing Jul. 23 at 2:44 AM

$BBNX Bullish PT 16

1 · Reply

P3acemaker Jul. 22 at 11:10 PM

$BBNX super bullish heading into earnings next week - plus the 18% of shares currently shorted still have to cover!! (translation: lots and lots of future buying pressure)

0 · Reply

SmallCapWinz Jul. 14 at 4:15 PM

$BBNX Feeling a strong bounce off the $12.50 level. Excellent Q&A during Q1 earnings. Strong pipeline of business activities. Now add the Abbott partnership into the mix. Averaging down here before Q2 earnings.

1 · Reply

Nicky23 Jul. 2 at 3:28 PM

$BBNX cmon baby please come down to under 12 again so I can start reloading the boat here.

0 · Reply

jheerdink Jun. 30 at 4:15 PM

$MODD Modular Medical (Nasdaq: MODD) Unveils Updated Investor Presentation, Emphasizing Disruptive Business Model and Near-Term Milestones https://vistapglobal.com/modular-medical-nasdaq-modd-unveils-updated-investor-presentation-emphasizing-disruptive-business-model-and-near-term-milestones/ $DXCM $BBNX

0 · Reply

P3acemaker Jun. 25 at 10:05 PM

$BBNX holy shit look at the short interest on this baby - 18%!!!! Which would take 13 days to cover at current volume. Schwab says this stock is hard to borrow so it's not like they can stay short forever. This is an extremely bullish sign and partly accounts for the recent price drop IMO https://fintel.io/ss/us/bbnx

0 · Reply

ZacksResearch Jun. 23 at 4:21 PM

$BBNX teams up with $ABT — is this the game-changer for diabetes care? 🤔 🔗 Strategic agreement to integrate iLet Bionic Pancreas with Abbott's dual glucose-ketone sensor 🚀 Aiming to enhance patient outcomes and simplify diabetes management 🏆 Positions BBNX to capture more of the growing AID market Opportunity assessment here 👉 https://www.zacks.com/commentary/2535909/bbnx-stock-may-gain-from-abbott-deal-to-advance-ilet-integration?cid=sm-stocktwits-2-2535909-body&ADID=SYND_STOCKTWITS_TWEET_2_2535909_BODY

0 · Reply

ZacksResearch Jun. 23 at 3:08 PM

$BBNX just teamed up with Abbott — here's why that matters 👀 Beta Bionics is integrating its iLet system with a dual sensor to simplify and improve diabetes care, a move that could drive adoption and upside. Full story on the potential impact here 👉 https://www.zacks.com/stock/news/2535909/bbnx-stock-may-gain-from-abbott-deal-to-advance-ilet-integration?cid=sm-stocktwits-2-2535909-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2535909_TEASER

0 · Reply

IN0V8 Jun. 16 at 8:25 PM

$BBNX Buying opportunity Truist Securities initiates coverage with buy rating Truist Securities initiates coverage with target price $26.00

0 · Reply

JarvisFlow Jun. 16 at 4:06 PM

Truist Securities has updated their rating for Beta Bionics ( $BBNX ) to Buy with a price target of 26.

0 · Reply

JarvisFlow Jun. 12 at 12:30 PM

Lake Street has adjusted their stance on Beta Bionics ( $BBNX ), setting the rating to Buy with a target price of 30.

0 · Reply

1trendingup Jun. 2 at 6:14 PM

$BBNX lol been loading since low 10’s. Watch out $PODD we’re coming for you

0 · Reply

Market Cap	618.14M
Revenue (ttm)	65.12M
Net Income (ttm)	-54.76M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-84.09%
Debt to Equity Ratio	0.00

Volume	164,232
Avg Vol	564,540
Day's Range	N/A - N/A
Shares Out	43.47M
Stochastic %K	36%
Beta	N/A
Analysts	Strong Sell
Price Target	$23.44